Swarm Biotactics
Kassel-based bio-robotics startup building controllable cyborg insects with sensor backpacks and edge AI for silent, close-range ISR in GPS-denied environments.
Background
Swarm Biotactics was founded in 2024 in Kassel, Germany by Stefan Wilhelm (CEO) and Moritz Strube (CTO), with a U.S. subsidiary established in San Francisco.
The company emerged from the intersection of entomology, materials miniaturization, and defense electronics to address reconnaissance scenarios where conventional drones are too large, too loud, or too detectable.
The core product line consists of living insects fitted with custom miniaturized backpacks that integrate control electronics, multi-modal sensors, edge AI inference, swarm coordination algorithms, and secure communications.
The systems are designed to operate in cluttered, GPS-denied, or otherwise inaccessible environments, returning real-time ISR data without acoustic or visual signatures typical of mechanical platforms. No individual system designations have been publicly disclosed.
Swarm Biotactics goes to market directly to defense and national security customers. The company exhibited at Enforce Tac in Kassel to build defense-industry visibility.
By February 2026, headcount had grown to over 40 employees across the German headquarters and San Francisco subsidiary.
Linked records
Wired to the rest of BattlePolicy — the systems it builds in the Lexicon and the contracts it wins in the Procurement Tracker. Every link below is a record in our own datasets.
- none linked yet
- none linked yet
Financial footing
- €10M seed (Jun 2025)
- ~€13M total
- Reported NATO/Bundeswehr deployment (single-source, promotional)
- Backers: Vertex Ventures US (lead), Possible Ventures, Capnamic
Swarm Biotactics closed a €3 million pre-seed round prior to mid-2025. In June 2025, the company closed a €10 million seed round led by Vertex Ventures US, with participation from Possible Ventures and Capnamic; secondary profiles also name Energy Impact Partners and Picus Capital as investors in that period.
Total capital raised stands at approximately €13 million across both rounds. No post-money valuation has been publicly disclosed. The company has not reported revenue figures, backlog values, or ARR. Swarm Biotactics remains privately held with no public-market listing or disclosed plans for one.
Major customers & contracts
Swarm Biotactics has publicly claimed paying NATO customers, specifically naming the German Armed Forces (Bundeswehr) as a customer. No contract award documents, procurement reference numbers, ceiling values, or award dates have been publicly disclosed for the Bundeswehr relationship. The scope — whether evaluation units, a pilot program, or a standing supply arrangement — has not been specified in any official procurement notice or government release.
No other named national defense ministry, allied armed service, or intelligence agency has been publicly confirmed as a customer. The NATO and Bundeswehr customer claims originate from company-sourced or promotional reporting and have not been corroborated by independent contract records or government announcements.
Leadership & contact surface
Leadership: Stefan Wilhelm (co-founder)
Official site: https://www.swarm-biotactics.com
Competitive position
Swarm Biotactics operates in the covert close-range ISR segment against both conventional micro-drone firms and emerging bio-hybrid platforms. Against Teledyne FLIR's Black Hornet nano-UAV family, Swarm offers acoustic stealth and biological maneuverability in cluttered interiors that rotary-wing platforms cannot replicate, but lacks Black Hornet's years of combat-proven fielding and NATO qualification history. Against Planck Aerosystems and Shield AI in GPS-denied autonomy, Swarm's biological substrate removes mechanical failure modes but introduces biological lifecycle constraints that software-only autonomy stacks do not face.
Against academic bio-robotics programs at institutions like UC Berkeley that have demonstrated insect-mounted electronics, Swarm holds a commercialization and defense-customer-engagement lead, though those programs carry no IP licensing or production risk. The market is embryonic: no direct insect-cyborg competitor has reached series production. Swarm's principal structural risk is that the category itself remains unvalidated at operational scale.
Battlefield relevance
No confirmed combat use to date.
Sources & verification
- Swarm Biotactics official website
- https://vertexholdings.com/news/swarm-biotactics-raised-euro13m-to-advance-bio-robotics-from-lab-to-field/
- https://robohorizon.uk/en-us/news/2026/02/cyborg-insect-swarms-are-now-deployed-with-nato-forces/
- https://www.linkedin.com/posts/samirkhayat_biorobotics-defensetech-swarmintelligence-activity-7432795212923641856-otaB
- https://www.enforcetac.com/en/exhibitors/swarm-biotactics-gmbh-2533770
- https://startupintros.com/orgs/swarm-biotactics
- https://www.enforcetac.com/de-de/aussteller/swarm-biotactics-gmbh-2533770
- https://teeming.ai/j/werkstudent-working-student/d12b01ae-8f0e-c4ee-4d5f-2295132738af/swarm-biotactics/628c5f1c-ba49-40b6-aa6b-66a9a777477b
- https://www.armyrecognition.com/news/army-news/2026/nato-deploys-german-programmable-cyborg-insect-swarms-for-urban-and-tunnel-reconnaissance
- https://www.reddit.com/r/STEW_ScTecEngWorld/comments/1ricnb4/swarm_biotactics_deploys_operational_cyborg/
- https://robohorizon.de/de/news/2026/02/cyborg-insekten-nato-einsatz/
- https://www.linkedin.com/posts/mikekalil_the-german-startup-swarm-biotactics-is-pushing-activity-7433257182151733248-ywjN
- https://www.defencefinancemonitor.com/p/swarm-biotactics-strategic-technological
- https://app.dealroom.co/companies/swarm_biotactics
- https://www.linkedin.com/company/swarm-biotactics